The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of non-alcoholic steatohepatitis

Gut

Volumn 48, Issue 2, 2001, Pages 206-211

  Wigg, A J ^a   Roberts Thomson, I C ^a   Grose, R H ^a   Cummins, A G ^a   Dymock, R B ^a   McCarthy, P J ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

Endotoxin; Intestinal permeability; Non alcoholic steatohepatitis; Small intestinal bacterial overgrowth; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL OVERGROWTH; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOTOXEMIA; FATTY LIVER; FEMALE; HUMAN; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIMULUS LYSATE TEST; MALE; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; BREATH TESTS; CASE-CONTROL STUDIES; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; INTESTINES; LIMULUS TEST; MALE; MIDDLE AGED; PERMEABILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035125052     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.2.206     Document Type: Article

References (20)

1. Hepatic steatosis after intestinal bypass - Prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition
2. Recurrence of non-alcoholic steatohepatitis following liver transplantation
3. Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth
4. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth
5. Abnormalities of liver function and hepatic damage associated with total pareteral nutrition
6. Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline
7. Polymyxin B reduces total parenteral nutrition-associated hepatic steatosis by its antibacterial activity and by blocking deleterious effects of lipopolysaccharide
8. Endotoxin, Kupffer cells and alcoholic liver injury
9. The role of gut derived bacterial toxins (endotoxin) for the development of alcoholic liver disease in man
10. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis
11. 14C-D-xylose breath test
12. 14C]d-xylose breath test for bacterial overgrowth
13. AGA technical review on the evaluation and management of chronic diarrhea
14. Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in paediatric practice
15. "Hidden" endotoxin in plasma of patients with alcoholic liver disease
16. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: Its clinical significance
17. Non-alcoholic steatohepatitis: Another disease of affluence
18. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
19. Protection against endotoxic shock by a tumour necrosis factor receptor immunoadhesin
20. Elevated serum tumour necrosis factor-alpha concentrations and bioavailability in type 2 diabetics and patients with android type obesity